We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation Patients (CAAN-AF) (CAAN-AF)

This study is currently recruiting participants.
Verified December 2017 by Prashanthan Sanders, University of Adelaide
Sponsor:
ClinicalTrials.gov Identifier:
NCT01522898
First Posted: February 1, 2012
Last Update Posted: December 11, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Medtronic
St. Jude Medical
Boston Scientific Corporation
Information provided by (Responsible Party):
Prashanthan Sanders, University of Adelaide
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2022
  Estimated Primary Completion Date: January 2022 (Final data collection date for primary outcome measure)